NCT03848676View on ClinicalTrials.gov

Genomic and Phenotypic Determinants of Resistance to Immunotherapies in Multiple Myeloma

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

July 1, 2024

Study Completion Date

December 10, 2024

Conditions
Multiple Myeloma
Interventions
DIAGNOSTIC_TEST

Evaluation of patients resistance to immunotherapies in Multiple Myeloma

There are only collections of the samples.

Trial Locations (1)

10126

Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, Torino

All Listed Sponsors
lead

University of Turin, Italy

OTHER

NCT03848676 - Genomic and Phenotypic Determinants of Resistance to Immunotherapies in Multiple Myeloma | Biotech Hunter | Biotech Hunter